PF4 and Venous thrombosis: In recent reports, almost all the patients that presented post-COVID-19 vaccines thrombosis had high levels of antibodies to platelet factor 4 (PF4)–polyanion complexes identified by ELISA as well as other platelet-based activation assays24,25.